14-day Premium Trial Subscription Try For FreeTry Free

iShares Nasdaq Biotechnology Index Fund ETF Price (Quote)

$133.28
+0.260 (+0.195%)
At Close: May 07, 2024

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 IBB stock ended at $133.28. This is 0.195% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 0.81% from a day low at $132.47 to a day high of $133.54.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical iShares Nasdaq Biotechnology Index Fund prices

Date Open High Low Close Volume
Apr 02, 2024 $137.21 $137.21 $133.59 $133.89 1 384 046
Apr 01, 2024 $137.21 $137.21 $135.50 $136.81 1 435 112
Mar 28, 2024 $138.40 $138.40 $137.13 $137.22 1 439 688
Mar 27, 2024 $136.56 $137.81 $135.84 $137.79 1 242 584
Mar 26, 2024 $136.41 $137.20 $135.85 $135.87 1 146 611
Mar 25, 2024 $136.27 $136.94 $135.68 $136.01 1 117 502
Mar 22, 2024 $137.16 $137.38 $136.04 $136.25 2 011 084
Mar 21, 2024 $137.62 $138.61 $137.20 $137.23 1 622 109
Mar 20, 2024 $135.83 $136.61 $134.27 $136.49 1 829 731
Mar 19, 2024 $135.06 $136.35 $134.86 $136.14 1 272 751
Mar 18, 2024 $136.01 $136.43 $135.19 $135.26 1 673 712
Mar 15, 2024 $135.42 $136.99 $135.39 $135.92 2 381 719
Mar 14, 2024 $138.07 $138.24 $134.76 $135.71 2 745 532
Mar 13, 2024 $138.26 $139.26 $137.66 $138.26 1 197 018
Mar 12, 2024 $138.97 $138.97 $137.57 $138.04 1 427 744
Mar 11, 2024 $138.63 $140.00 $138.44 $138.70 1 236 832
Mar 08, 2024 $138.93 $140.22 $138.14 $138.65 1 992 179
Mar 07, 2024 $138.55 $139.16 $137.79 $138.32 1 824 346
Mar 06, 2024 $137.97 $138.51 $137.51 $137.87 1 288 642
Mar 05, 2024 $138.06 $139.05 $136.85 $137.34 1 700 583
Mar 04, 2024 $139.85 $140.14 $138.05 $138.51 2 096 108
Mar 01, 2024 $137.50 $140.44 $137.11 $139.81 2 385 966
Feb 29, 2024 $140.34 $140.64 $136.83 $136.84 2 581 878
Feb 28, 2024 $140.41 $140.77 $139.32 $139.42 2 956 383
Feb 27, 2024 $139.65 $141.15 $138.79 $140.89 2 321 061
Click to get the best stock tips daily for free!

About iShares Nasdaq Biotechnology Index Fund

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representin... IBB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT